Health
Mefloquine shows potential as anti-SARS-CoV-2 drug – News-Medical.Net
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome…
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specifically, mefloquine has been shown to prevent the entry of SARS-CoV-2 into host cells and reduce the viral loadin vitro. The study is currently available on the bioRxiv* preprint server.
The recent pandemic of coronavirus disease 2019 (COVID-19) has put a substantial amount of burden on healthcare…
-
General17 hours agoMan dies in daylight shooting in Sydney’s north-west
-
Noosa News18 hours agoGlencore receives taxpayer bailout to save Mt Isa mining jobs
-
Business20 hours agoOrd Minnett names 2 ASX 200 shares to buy
-
Noosa News21 hours agoResident rushed to hospital with multiple burns as house engulfed in flames in Woodridge